CM
Insider
Charles N. Mills
DirectorCharles N. Mills (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Medline Inc. (MDLN). Across 1 priced purchase filing, the average 21-session return was +15.7% from execution and +9.2% from disclosure (delay-adjusted; derived). The largest single filing was $74.8M of MDLN (2,579,310 sh across 2 lots, as filed), executed Dec 18 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+15.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+9.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$74.8M
shares × price, as filed
Last traded
Dec 18 2025
Filed Dec 22 2025
Median ADV $395.8M across their filed names
Open performance→Volume by month
Buys $74.8M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MDLNRecent filings
MDLNPURCHASE
Medline Inc.
View filing →
$74.8M2,579,310 sh across 2 lots
Exec Dec 18 2025
Filed Dec 22 2025 · 4:30 PM ET